SkinCeuticals C E Ferulic
C E Ferulic is a revolutionary patented triple antioxidant serum that delivers 8x skin's natural environmental protection against UVA/UVB rays. This serum helps neutralize free radicals induced by UVA/UVB rays, infrared radiation (IRA), and ozone pollution (O3), which may lead to visible signs of skin aging.
Key Benefits of SkinCeuticals C E Ferulic
- Provides superior antioxidant protection against UV rays, pollution, and infrared radiation (IRA)
- Improves firmness and reduces the appearance of fine lines and wrinkles, and brightens skin's complexion.
- Once absorbed remains effective for 72 hours
- Tested suitable for post-laser skin (non-ablative and ablative fractional) - always consult with a physician for individual post-procedure care.
Clinical Study Results
Clinical improvement in firmness, elasticity, and wrinkles
- 28% improvement in fine lines
- 31% improvement in skin firmness
- 32% improvement in wrinkles
Protocol: 16-week clinical study conducted on 50 Caucasian male and female subjects ages 40-60 years old (USA, 2013). Product applied once daily in the morning. For controlled results, subjects used SkinCeuticals Gentle Cleanser and Ultimate UV Defense SPF 30 daily, and emollience moisturizer as needed.
Environmental protection against UVA/UVB
- Significant reduction in thymine dimer count (DNA mutations caused by UVA radiation and associated with skin cancer).
According to a publication in the Journal Of Cosmetic Dermatology, 7 2008 (P. 290-297)
Environmental protection against IR-A
- 62% reduction in MMP-1 (an infrared-induced collagen-degrading enzyme).
According to a publication in photodermatal Photoimmunol Photomed 2014: 30: (P. 167-174)
Environmental protection against ozone pollution
- 52% reduction in HNE levels (HNE proteins are a marker of lipid peroxidation in the skin, generated by free radical attack on fatty acids in skin exposed to ozone. Their reduction indicated the reduction of cellular damage).
According to a SkinCeuticals study, accepted to be published in the Journal of Investigative Dermatology in 2017